









Markets
/
Stocks
/
nasdaq-atpc
/

Agape ATP Corp

ATPC

1.290USD

-0.030-2.29%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

64.51MMarket Cap

LossP/E TTM



Agape ATP Corp

1.290

-0.030-2.29%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Despite an average stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

148 / 207

Overall Ranking

453 / 4720

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. The Company offers four series of products: ATP Zeta Health Program, ENERGETIQUE, BEAUNIQUE and E.A.T.S. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake and unhealthy lifestyles. ENERGETIQUE series consists of the energy mask series, hyaluronic acid and mousse facial cleanser. Its BEAUNIQUE product series focuses on the research of its diet’s impact on modifying gene expressions in order to address genetic variations and deliver a personalized nutrigenomic solution for every individual.

Growing

The company is in a growing phase, with the latest annual income totaling USD 1.32M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 46.45.

Fairly Valued

The company’s latest PE is -3.40, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 26.66M shares, increasing 48.58% quarter-over-quarter.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 6.28, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 465.50K, representing a year-over-year increase of 48.70%, while its net profit experienced a year-over-year increase of 39.39%.

Score

Industry at a Glance

Previous score

6.28

Change



Financials

6.61

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.87

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.59

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.18

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.13

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 2.80, which is lower than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is -3.37, which is -17.96% below the recent high of -2.77 and -136.16% above the recent low of -7.97.

Score

Industry at a Glance

Previous score

2.80

Change

1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 148/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

There is no earnings forecast score for this company; the Healthcare Equipment & Supplies industry's average is 7.70.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 2.97, which is lower than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 1.40 and the support level at 1.21, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

2.97

Change

0.04

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.002

Sell

RSI(14)

46.114

Neutral

STOCH(KDJ)(9,3,3)

18.689

Neutral

ATR(14)

0.048

High Vlolatility

CCI(14)

-49.937

Neutral

Williams %R

75.000

Sell

TRIX(12,20)

-0.093

Sell

StochRSI(14)

41.711

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.290

Sell

MA10

1.302

Sell

MA20

1.315

Sell

MA50

1.330

Sell

MA100

1.508

Sell

MA200

1.414

Sell

Institutional Confidence

Currency: USD Updated: 2025-09-19

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Lesser Panda Ltd

3.68M

Global Fartech Ltd

3.45M

Nexus Investments Group Ltd

3.04M

Oceanic Equity Partner Ltd

3.03M

Blue Horizon Capital Ltd

3.03M

Global Ascend Ventures Ltd

3.02M

Vanguard Development Holdings Ltd

3.02M

Evergreen Strategic Capital Holding Ltd

3.01M

Choong (How Kok)

980.45K

+0.06%

HKC Talent, Ltd

385.75K

-6.43%

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.22, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.